Press Release: Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 study

Sanofi’s efdoralprin alfa met all primary and key secondary endpoints in alpha-1 antitrypsin deficiency emphysema phase 2 studyEfdoralprin alfa ...
pharmaphorum

Wave surges on first RNA editing data in humans

Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...
pharmaphorum

Sanofi snaps up Inhibrx and its rare disease drug for $2.2bn

A slew of pharma mergers and acquisitions in the first month of 2024 has continued with a $2.2 billion play by Sanofi for Inhibrx and its clinical-stage drug candidate for alpha-1 antitrypsin ...
Yahoo Finance

CRISPR Therapeutics AG (CRSP)

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. CRISPR Therapeutics AG ...
Evening Chronicle

Traffic & Travel

All the latest live Newcastle travel, traffic and weather information from across the city of Newcastle-upon-Tyne and the North East. Live traffic updates about roadworks, traffic incidents on the A1, ...
gadgets360

Redmi A1+

Redmi A1+ mobile was launched on 14th October 2022. The phone comes with a 6.52-inch touchscreen display offering a resolution of 1600x700 pixels (HD+) at a pixel density of 400 pixels per inch (ppi) ...